Rate this page:
Poor |
Satisfactory |
Good |
ExcellentPrint/View WholeSend Feedback
Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
Title: Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study.
Month: February
Volume: 59
Issue: 2
Page(s): pp. 56–59
Efficacy Study/Review:
Yes Keywords:
Adolescent / Secondary School Age,
Anxiety/Fear,
Anxiolytics,
Autism,
Autistic Disorder,
Buspirone,
Child/Children,
Intervention,
Irritability,
Medication,
Pervasive Developmental Disorder (Not Otherwise Specified),
Primary / Elementary School Age
Please note that Research Autism is unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library, the National Autistic Society's Information Centre (Open in new window) or direct from the publisher.
Publications Database |
Search Publications |
Publications Help
Back To Top